AMRN Amarin Corporation plc

NASDAQ
$14.07

Amarin Corporation plc (AMRN) is expected to report earnings on October 28, 2026, before the market open. The consensus earnings estimate is a loss of $0.33 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +0.6% since its last earnings release on July 29, 2026.

Amarin Corporation plc Beat Consensus Estimates
Wednesday, July 29, 2026 · 7:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Oct 28
Wednesday · 7:00 AM ET
Earnings Whisper
-
vs ($0.33)
Rev est $44.49M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $14.20

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Amarin Corporation plc

Amarin Corp PLC is a biopharmaceutical company with expertise in lipid science. The Company is engaged in commercialization and development of therapeutics to improve cardiovascular health.

Sector

Healthcare

Industry

Drug Delivery